Potential anti-tumor effect of a nanoliposomal antiPCSK9 vaccine in mice bearing colorectal cancer

INTRODUCTION: Inhibition of proprotein convertase subtilisin/kexin 9 (PCSK9) is an effective therapeutic tool for lowering low-density lipoprotein cholesterol (LDL-C). There is no available evidence on the efficacy and safety of PCSK9 inhibitors in non-cardiovascular diseases, particularly cancer. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Momtazi-Borojeni, Amir Abbas, Nik, Maryam Ebrahimi, Jaafari, Mahmoud Reza, Banach, Maciej, Sahebkar, Amirhossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2019
Materias:
Hot Topics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524180/
https://www.ncbi.nlm.nih.gov/pubmed/31110520
http://dx.doi.org/10.5114/aoms.2019.84732

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524180/
https://www.ncbi.nlm.nih.gov/pubmed/31110520
http://dx.doi.org/10.5114/aoms.2019.84732

Ejemplares similares